author-photo

Katia Alves

Merck & Co.

22

Papers

412

Citations

Citation Trend

Filter By

Papers (19) Sort By

Journal Conference Others

LBP-12-Phase 1a Study of the Safety, Tolerability and Pharmacokinetics of ABI-H, a Novel Second-Generation HBV Core Inhibitor, in Healthy Volunteers

2019 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (3)
Pharmacokinetics of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir in Healthy Chinese Subjects and HCV GT1b-Infected Chinese, South Korean and Taiwanese Patients

2019 European Journal of Drug Metabolism and Pharmacokinetics
Show All
- Source
- Cite
- Save
Citations (1)
Resistance characterization of hepatitis C virus genotype 2 from Japanese patients treated with ombitasvir and paritaprevir/ritonavir

2018 Journal of Medical Virology
Show All
- Source
- Cite
- Save
Citations (12)
IDDF2018-ABS-0067 Efficacy and safety of glecaprevir/pibrentasvir in patients with hcv genotype 5 or 6 infection: the endurance-5, 6 study

2018 Gut
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis

2018 Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (83)
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with HCV Genotype 5 or 6 Infection: The ENDURANCE-5,6 Study

2018 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (3)
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis

2018 Annals of Hepatology
Show All
- Source
- Cite
- Save
Citations (3)
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection with and without cirrhosis

2017 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (1)
Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection

2017 Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (89)
Randomized Phase 3 Trial of Ombitasvir/Paritaprevir/Ritonavir and Ribavirin for Hepatitis C Virus Genotype 2-Infected Japanese Patients

2017 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (14)